22 September 2022
Message from the UK CPhOs regarding membership of the working groups for the UK Commission on Pharmacy Professional Leadership
Please see below for a message from the UK Commission CPhOs:
We are delighted to share the membership of the working groups for the UK Commission on Pharmacy Professional Leadership and offer congratulations to those who have been appointed.
Professional leadership has never been so important. There are significant changes impacting on the pharmacist and pharmacy technician professions and we need to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from best practice.
Strong, effective and well-respected professional leadership, which represents the clinical voice of pharmacy professionals, is required to guide, support and enable these transformational changes so they benefit patients and professionals.
The overall purpose of professional leadership is to influence, promote, and support the delivery of the highest possible standards of professional practice to continue to drive up the quality of patient care.
The Commission is intended to be an inclusive UK-wide conversation to learn and determine how pharmacy professional leadership can be strengthened to support practising professionals, professional regulation and pharmacy professional representation to enable excellence in patient care.
Commission members have been appointed on behalf of all pharmacy professionals to contribute their expertise in and knowledge of professional leadership and are not appointed to represent their particular countries, organisations, sectors or roles.
Working group members have been invited to join the five groups by the UK Chief Pharmaceutical Officers (CPhOs), in consultation with the working group chair and deputy chair, and 13 working group members have been selected through an Inclusive Pharmacy Practice expression of interest process.
The five working groups, chaired by Commission members, will each meet twice between 18 October to 4 November 2022 and take forward work on the key themes.
Members will receive the Commission’s Call for Evidence report on 11 October 2022 and each group will be asked to produce a set of recommendations for the main Commission by 18 November 2022. Meetings will be set up by the relevant UK CPhO’s secretariat team who will be in touch very soon.
In December the Commission will meet again to consider the working group recommendations and develop its report. Currently it aims to publish its final report and recommendations in January 2023.
For further details about the Commission and the Call for Evidence, which closes on 28 September 2022, please see https://bit.ly/3AsyfbS.
Thank you for your valuable contribution to this important work.
Andrew Evans, Chief Pharmaceutical Officer for Wales
Cathy Harrison, Chief Pharmaceutical Officer for Northern Ireland
Alison Strath, Chief Pharmaceutical Officer for Scotland
David Webb, Chief Pharmaceutical Officer for England